CDC Takes Action

Minor and harmless mishaps at small labs are part of the fun of science and make good yarn-swapping for old science vets. But accidents that expose people to deadly pathogens are not so funny to the Centers for Disease Control and Prevention, which has temporarily shut down its anthrax and flu labs and halted shipments of all infectious agents out of its highest-security labs, the New York Times reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.